Episode Details

Back to Episodes
The study on the treatment of myeloid malignancies with the novel BCLtwo inhibitor Mesutoc

The study on the treatment of myeloid malignancies with the novel BCLtwo inhibitor Mesutoc

Published 3 months ago
Description
Smf5Yv7iSAZW7lGwgunC
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us